Get started
Author

Brice Mayor

Observed names: B. Mayor, Brice MAYOR, Brice Major, Delia May
OpenAlex ID: A5087764148
High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
2009 · G. Jean, J.-C. Terrat, et al. · Nephrology Dialysis Transplantation · 351
Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences
2008 · G. Jean, E. Bresson, et al. · Nephrology Dialysis Transplantation · 227
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients
2020 · Cécile Couchoud, Florian Bayer, et al. · Kidney International · 148
PDF
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers
2008 · G. Jean, J.-C. Terrat, et al. · Nephrology Dialysis Transplantation · 111
Evidence for Persistent Vitamin D 1-Alpha-Hydroxylation in Hemodialysis Patients: Evolution of Serum 1,25-Dihydroxycholecalciferol after 6 Months of 25-Hydroxycholecalciferol Treatment
2008 · G. Jean, J.C. Terrat, et al. · Nephron Clinical Practice · 83
Multiphasic effects of blood pressure on survival in hemodialysis patients
2016 · Thierry Hannedouche, Hubert Roth, et al. · Kidney International · 60
Predicting Glomerular Filtration Rate in Kidney Transplantation: Are the K/DOQI Guidelines Applicable?
2005 · Christophe Mariat, Eric Alamartine, et al. · American Journal of Transplantation · 59
Increased Levels of Serum Parathyroid Hormone and Fibroblast Growth Factor-23 Are the Main Factors Associated with the Progression of Vascular Calcification in Long-Hour Hemodialysis Patients
2012 · Guillaume Jean, Eric Bresson, et al. · Nephron Clinical Practice · 48
Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients
2011 · C. Chazot, C. Vo-Van, et al. · Nephrology Dialysis Transplantation · 46
Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study
2015 · Guillaume Jean, Jean-Marc Hurot, et al. · BMC Nephrology · 33
PDF
Brain Natriuretic Peptide Is a Marker of Fluid Overload in Incident Hemodialysis Patients
2017 · Charles Chazot, Margaux Rozes, et al. · Cardiorenal Medicine · 32
Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone
2012 · Guillaume Jean, Brice Mayor, et al. · Nephrology Dialysis Transplantation · 29
Predialysis Systolic Blood Pressure Evolution in Incident Hemodialysis Patients: Effects of the Dry Weight Method and Prognostic Value
2012 · Charles Chazot, Cyril Vo-Van, et al. · Blood Purification · 28
Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease
2012 · Guillaume Jean, Jean-Claude Souberbielle, et al. · Clinical Biochemistry · 25
La calciphylaxie chez le patient dialysé : la reconnaître pour la traiter aussitôt que possible
2010 · Guillaume Jean, Jean-Claude Terrat, et al. · Néphrologie & Thérapeutique · 21
Even a Moderate Fluid Removal Rate during Individualised Haemodialysis Session Times Is Associated with Decreased Patient Survival
2017 · Charles Chazot, Cyril Vo-Van, et al. · Blood Purification · 16
Usefulness and feasibility of measuring ionized calcium in haemodialysis patients
2015 · Guillaume Jean, Samuel Granjon, et al. · Clinical Kidney Journal · 15
PDF
Vascular Calcification Progression Is an Independent Predictor of Mortality in Patients on Haemodialysis
2015 · Guillaume Jean, Brice Mayor, et al. · The Nephron journals/Nephron journals · 15
Target Weight Gain during the First Year of Hemodialysis Therapy Is Associated with Patient Survival
2014 · Charles Chazot, Patrik Deleaval, et al. · Nephron Clinical Practice · 15
Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort
2018 · Guillaume Jean, Marie Hélène Lafage-Proust, et al. · PLoS ONE · 11
PDF
Treating mineral metabolism disorders in patients undergoing long hemodialysis: A search for an optimal strategy
2009 · Guillaume JEAN, Thierry VANEL, et al. · Hemodialysis International · 11
Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients
2016 · Guillaume Jean, Jean-Claude Souberbielle, et al. · BMC Nephrology · 10
PDF
Traitement de l’hyperparathyroïdie secondaire, résistante aux thérapeutiques conventionnelles, et de l’hyperparathyroïdie tertiaire par le cinacalcet : une stratégie efficace
2010 · Guillaume Jean, Thierry Vanel, et al. · Néphrologie & Thérapeutique · 9
Quels marqueurs osseux chez les patients hémodialysés : phosphatases alcalines osseuses ou ß-CrossLaps ?
2013 · Guillaume Jean, Jean-Claude Souberbielle, et al. · Néphrologie & Thérapeutique · 7
Que faire de ces valeurs d’hormones parathyroïdiennes réputées trop basses chez les patients dialysés ?
2012 · Guillaume Jean, Marie-Hélène Lafage-Proust, et al. · Néphrologie & Thérapeutique · 6
Works count: 66
Citation count: 1,494
H-index: 16
I10-index: 23
Year
Topic
Type